Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

Nintendo Switch | Switch Sports | 12 months Switch Online | £259.99 £258.99 at Amazon Save £1 - Yes, this saving is technically only £1, but that's because it's a discount on the bundle price.

Open-backed wired over-ear headphones that easily trounce all rivals at the level – and I don't say that lightly ...

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.